找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: EGF Receptor in Tumor Growth and Progression; R. B. Lichtner,R. N. Harkins Conference proceedings 1997 Springer-Verlag Berlin Heidelberg 1

[复制链接]
楼主: Addiction
发表于 2025-3-23 09:50:25 | 显示全部楼层
House Church Christianity in Chinarials is the understanding that the whole epithelial lining of the tract shares a common carcinogenic exposure, resulting in an increased cancer risk throughout the exposed epithelum. This entire epithelium was first described as “condemned mucosa” associated with “field cancerization” by Slaughter
发表于 2025-3-23 17:48:05 | 显示全部楼层
发表于 2025-3-23 21:20:09 | 显示全部楼层
0947-6075 and progression of cancer. Early breakthroughs defining growth control pathways came via studies of oncogenes, mutated signaling molecules that have lost the capacity to tum off their proliferative signal. Oncogenes with diverse growth-promoting activities have been discovered, covering the gamut fr
发表于 2025-3-24 01:52:00 | 显示全部楼层
发表于 2025-3-24 04:15:03 | 显示全部楼层
发表于 2025-3-24 06:49:20 | 显示全部楼层
Real Sandpiles and Landscape Formation,nt toxin constructs are currently being tested in cancer therapy. The new strategies still employ the two original principles: (1) they rely on the enhanced expression of cell surface molecules in tumor cells when compared to normal cells, and (2) they utilize bifunctional molecules combining a tumor cell recognition domain and a toxic domain.
发表于 2025-3-24 13:32:53 | 显示全部楼层
ainsbury et al. 1985; Harris et al. 1989), and lung (Veale et al. 1987; Hendler et al. 1989). Furthermore, EGF receptor activation has been implicated in autocrine stimulation of cell growth in many experimental studies (Mendelsohn 1990). Therefore, the EGF receptor appears to be an excellent target for antitumor therapy (Mendelsohn 1989).
发表于 2025-3-24 17:12:11 | 显示全部楼层
EGF Receptors as a Target for Therapy and Interactions with Angiogenesis,nd in vivo assays and commonly unregulated in cancer with a poor prognosis, its potential as a therapy target has been investigated and clinical trials are now in progress. This article reviews the clinical background and some recent developments with implications for therapy.
发表于 2025-3-24 21:11:29 | 显示全部楼层
erbB Signalling and Endocrine Sensitivity of Human Breast Cancer, loss of suppressor gene function (Walker and Varley 1993), ultimately alter the phenotype of cancer cells and allow them to thrive under conditions in which their normal counterparts remain severely growth restrained (Gee et al. 1996; Nicholson and Gee 1996).
发表于 2025-3-24 23:29:17 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-7 17:00
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表